RespireRx Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$2,022,267 over the previous period. Total operating expenses were $1,579,355.
Profit Margin
| 2013 | 0 | -1.20M | |
|---|---|---|---|
| 2014 | 61.66K | -2.70M | -4390.57% |
| 2015 | 86.91K | -5.96M | -6859.37% |
| 2016 | 0 | -9.22M | |
| 2017 | 0 | -4.29M | |
| 2018 | 0 | -2.59M | |
| 2019 | 0 | -2.51M | |
| 2020 | 0 | -4.84M | |
| 2021 | 0 | -3.86M | |
| 2022 | 0 | -2.02M |
RSPI Income Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 86.91K | 61.66K | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 5.16K | 6.95K | 1.70K | 591 | 0 |
Gross profit | 0 | 0 | 0 | 0 | 0 | -5.16K | -6.95K | 85.20K | 61.07K | 0 |
Operating exp. | ||||||||||
Research and development | 429.53K | 702.04K | 638.27K | 599.32K | 688.28K | 1.73M | 3.17M | 1.70M | 591.76K | 206.91K |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 1.57M | 2.55M | 3.31M | 1.73M | 2.17M | 4.24M | 8.47M | 5.32M | 4.41M | 1.13M |
Operating income | -1.57M | -2.55M | -3.31M | -1.73M | -2.17M | -4.24M | -8.47M | -5.23M | -4.35M | -1.13M |
Other income (expenses), net | -523.36K | -585.71K | -986.07K | -378.52K | -279.02K | -44.07K | -171.53K | -722.27K | 1.64M | -5.23K |
Income before tax | -2.10M | -3.14M | -4.30M | -2.11M | -2.59M | -4.29M | -9.22M | -5.96M | -2.70M | -1.20M |
Income tax expense | -80.45K | 724.76K | 545.67K | 404.66K | 279.02K | 44.07K | 757.87K | 722.27K | -1.64M | 7.22K |
Net income | -2.02M | -3.86M | -4.84M | -2.51M | -2.59M | -4.29M | -9.22M | -5.96M | -2.70M | -1.20M |
Earnings per share | ||||||||||
Basic EPS | -0.01 | -0.04 | -0.19 | -6.45 | -7.73 | -17.75 | -49.51 | -50.4 | -45.65 | -27.11 |
Diluted EPS | -0.01 | -0.04 | -0.19 | -6.45 | -7.73 | -17.75 | -49.51 | -50.4 | -45.65 | -27.11 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |